Development of resistance to one type of lipophilic chemotherapeutic drug often leads to resistance to other, structurally unrelated, lipophilic drugs. This suggests that non-toxic lipophilic agents may interfere with and reverse drug resistance by saturating the pathway through which multidrugresis
Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells
β Scribed by Dr Antonella Pannocchia; Silvia Revelli; Giacomo Tamponi; Angelica Giorgianni; Roberta Todde; Amalia Bosia; Dario Ghigo
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 595 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0263-6484
- DOI
- 10.1002/cbf.641
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Multidrug resistant (MDR) tumor cells exhibit an altered pH gradient across different cell compartments, which favors a reduced intracellular accumulation of antineoplastic drugs and a decreased therapeutic effect. In our study, we have observed that the activity and expression of Na^+^
Four human colon cancer cell lines (SW620, LS 180, DLD-I, and HCT-15) and sub-lines isolated in vitro by selection with Adriamycin were studied for reversal of intrinsic and acquired Adriamycin resistance, using buthionine sulfoximine (BSO) to deplete cellular glutathione alone and in combination wi
## Abstract We studied the restoration of doxorubicin accumulation and sensitivity by verapamil and quinine in a variant of the human erythroleukemia cell line K562 selected for resistance to doxorubicin and presenting a multidrugβresistance (MDR) phenotype. Verapamil was able to completely restore